Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026799
Filing Date
2018-05-10
Accepted
2018-05-10 06:14:51
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv492677_10q.htm 10-Q 294118
2 EXHIBIT 31.1 tv492677_ex31-1.htm EX-31.1 9635
3 EXHIBIT 31.2 tv492677_ex31-2.htm EX-31.2 9550
4 EXHIBIT 32.1 tv492677_ex32-1.htm EX-32.1 4741
  Complete submission text file 0001144204-18-026799.txt   3633674

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20180331.xml EX-101.INS 782932
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20180331.xsd EX-101.SCH 42430
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20180331_cal.xml EX-101.CAL 21734
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20180331_def.xml EX-101.DEF 265884
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20180331_lab.xml EX-101.LAB 333381
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20180331_pre.xml EX-101.PRE 296661
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 18820361
SIC: 2834 Pharmaceutical Preparations